DT&CRO Co (XKRX:383930) Dividend Payout Ratio : 0.00 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is DT&CRO Co Dividend Payout Ratio?

DT&CRO Co's dividend payout ratio for the months ended in Mar. 2024 was 0.00.

The historical rank and industry rank for DT&CRO Co's Dividend Payout Ratio or its related term are showing as below:

XKRX:383930's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.435
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-20), the Dividend Yield % of DT&CRO Co is 0.00%.

DT&CRO Co's Dividends per Share for the months ended in Mar. 2024 was ₩0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

DT&CRO Co Dividend Payout Ratio Historical Data

The historical data trend for DT&CRO Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DT&CRO Co Dividend Payout Ratio Chart

DT&CRO Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dividend Payout Ratio

DT&CRO Co Quarterly Data
	Jun21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Dividend Payout Ratio	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of DT&CRO Co's Dividend Payout Ratio

For the Biotechnology subindustry, DT&CRO Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DT&CRO Co's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DT&CRO Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where DT&CRO Co's Dividend Payout Ratio falls into.

DT&CRO Co Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

DT&CRO Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2023 )	/	EPS without NRI (A: Dec. 2023 )
	=	0	/	-909.145
	=	N/A

DT&CRO Co's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2024 )	/	EPS without NRI (Q: Mar. 2024 )
	=	0	/	-365.631
	=	N/A

DT&CRO Co (XKRX:383930) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

DT&CRO Co Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of DT&CRO Co's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

DT&CRO Co (XKRX:383930) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DT&CRO Co Ltd (XKRX:383930) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

28, Baengnyeong-ro 20beon-gil, 2nd, 3rd, 4th floor, Na-dong, Cheoin-gu, Gyeonggi-do (Yubang-dong), Yongin-si, KOR, 17042

Website

http://www.dtncro.com

DT&CRO Co Ltd conducts a series of consigned research, from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics and medical devices, to analysis, bioactivity, clinical trials, and licensing consulting. provided as a service.

DT&CRO Co (XKRX:383930) Headlines

No Headlines